| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2017 | Brain metastases in patients with non-small cell lung cancer: the role of mutated-EGFRs with an exon 19 deletion or L858R point mutation in cancer cell dissemination. | Hsiao, SH; Chou, YT; Lin, SE; Hsu, RC; Chung, CL; Kao, YR; Liu, HE; Wu, CW | Oncotarget 8(32), 53405-53418 | | | |
| 2010 | EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. | Chou, YT; Lin, HH; Lien, YC; Wang, YH; Hong, CF; Kao, YR; Lin, SC; Chang, YC; Lin, SY; Chen, SJ; Chen, HC; Yeh, SD; Wu, CW | Cancer research 70(21), 8822-8831 | | | |
| 2018 | Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma. | Hong, SY; Kao, YR; Lee, TC; Wu, CW | Cancer research 78(17), 4984-4996 | | | |
| 2017 | YAP1 is essential for tumor growth and is a potential therapeutic target for EGFR-dependent lung adenocarcinomas. | Lee, TF; Tseng, YC; Chang, WC; Chen, YC; Kao, YR; Chou, TY; Ho, CC; Wu, CW | Oncotarget 8(52), 89539-89551 | | | |
